AstraZeneca PLC May 2026 Form 6-K: Total Voting Rights and Share Admission Notification

AstraZeneca PLC filed a Form 6-K for May 2026, providing two key notifications. First, the company reported total voting rights as of April 30, 2026, consisting of 1,550,995,630 ordinary shares of US$0.25 each, with no shares held in Treasury. Second, the company notified the admission of 14,807 additional securities to trading on the London Stock Exchange's Main Market. These new shares were issued between April 1-30, 2026, under the company's existing block admission dated January 29, 2021, and are fully fungible with existing ordinary shares. The admission relates to shares issued under AstraZeneca's employee share schemes. The total number of securities in issue following this admission remains 1,550,995,630, indicating these shares were already included in the previously reported total voting rights figure.